Fungal infections in pediatric intensive care units

Maurizio Evangelista, Gabriele Finco, Daniela Sanna, Paolo Mura, Mario Musu

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

3 Citazioni (Scopus)

Abstract

Pediatric fungal infections are associated with significant morbidity and mortality. Few adequately powered antifungal trials have been performed in neonates and children. Neonatologists and pediatricians are reliant on adult trials when managing candidemia. Recent guidelines from the Infectious Diseases Society of America recommend fluconazole or an echinocandin for empiric therapy in suitable candidates, with a preference for an echinocandin in patients with moderate-to severe disease, recent azole exposure, or high risk of C. glabrata or C. krusei infection
Lingua originaleEnglish
pagine (da-a)22-24
Numero di pagine3
RivistaTHE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Volume24
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Adult
  • Antifungal Agents
  • Chemoprevention
  • Child
  • Echinocandins
  • Humans
  • Infant
  • Intensive Care Units
  • Mycoses
  • Newborn
  • Pediatric
  • Risk Factors

Fingerprint Entra nei temi di ricerca di 'Fungal infections in pediatric intensive care units'. Insieme formano una fingerprint unica.

Cita questo